Tuesday, August 17, 2021 4:38:15 AM
Positions STRATA as the predominant provider of excimer laser treatments to address the $6 billion U.S. market for the treatment of chronic skin diseases
Delivers added long-term recurring revenue growth potential and prospective customer base
Increases competitive positioning with more than 400 U.S. dermatology practices
HORSHAM, Pa., Aug. 16, 2021 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic conditions, today announced the acquisition of the U.S. dermatology business of Ra Medical.
The transaction immediately provides STRATA with the opportunity to market its full business solution to Ra Medical’s existing customer base of 400 dermatology practices, thus making way for STRATA to substantially increase its recurring revenue base in the future. It also provides a highly synergistic path to gain additional placements for STRATA’s XTRAC excimer laser system...
20% of life is what happens to you and 80% is how you react to what happens to you...
Recent SSKN News
- STRATA Skin Sciences to Present at the iAccess Alpha - Buyside Best Ideas Fall Conference 2024 • GlobeNewswire Inc. • 09/17/2024 12:15:00 PM
- STRATA Skin Sciences to Participate in the Lake Street Capital Markets 8th Annual Best Ideas Growth Conference • GlobeNewswire Inc. • 09/05/2024 12:15:00 PM
- STRATA Skin Sciences to Present at the H.C. Wainwright 26th Annual Global Investment Conference • GlobeNewswire Inc. • 09/03/2024 12:15:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/26/2024 12:00:22 PM
- STRATA Skin Sciences Files Complaint Against LaserOptek, Monarch Laser Services, and The Pinnacle Health Group • GlobeNewswire Inc. • 08/26/2024 12:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2024 09:19:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/14/2024 08:15:44 PM
- STRATA Skin Sciences Reports Second Quarter 2024 Financial Results and Provides a Corporate Update • GlobeNewswire Inc. • 08/14/2024 08:05:00 PM
- STRATA Skin Sciences to Report Second Quarter 2024 Financial Results on August 14, 2024 and Provide Corporate Update • GlobeNewswire Inc. • 08/07/2024 12:15:00 PM
- STRATA Skin Sciences to Participate in the 9th Annual Virtual Needham MedTech & Diagnostics 1x1 Conference • GlobeNewswire Inc. • 08/06/2024 12:15:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/23/2024 09:00:18 PM
- STRATA Skin Sciences Completes $2.1 Million Direct Offering With Participation from Insiders • GlobeNewswire Inc. • 07/23/2024 12:00:00 PM
- STRATA Skin Sciences Announces Approval of XTRAC Momentum™ 1.0 Device in Japan • GlobeNewswire Inc. • 07/22/2024 12:00:00 PM
- Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend] • Edgar (US Regulatory) • 07/18/2024 11:42:09 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/17/2024 09:08:57 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/17/2024 09:08:11 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/17/2024 09:01:09 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/17/2024 12:00:25 PM
- STRATA Skin Sciences’ TheraClear®X Acne Therapy System Found Safe and Effective in Study Published in Peer Reviewed Journal • GlobeNewswire Inc. • 07/17/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/11/2024 12:00:44 PM
- STRATA Skin Sciences Pre-Announces Second Quarter 2024 Financial Results • GlobeNewswire Inc. • 07/11/2024 12:00:00 PM
- STRATA Skin Sciences Sponsors Webinars Featuring Leading Dermatologists Discussing Benefits of XTRAC® and TheraClear®X Devices • GlobeNewswire Inc. • 06/12/2024 12:00:00 PM
- STRATA Skin Sciences’ TheraClear®X Acne Therapy System Found to be Safe and Effective for Acne Lesions Across All Fitzpatrick Skin Types with Favorable Tolerability and Patient Satisfaction as Published in Peer Reviewed Journal • GlobeNewswire Inc. • 06/07/2024 12:15:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/04/2024 08:30:42 PM
- STRATA Skin Sciences to Participate in June Dermatology Conferences • GlobeNewswire Inc. • 06/04/2024 12:00:00 PM
North Bay Resources Commences Operations at Bishop Gold Mill, Inyo County, California; Engages Sabean Group Management Consulting • NBRI • Sep 25, 2024 9:15 AM
CEO David B. Dorwart Anticipates a Bright Future at Good Gaming Inc. Through His Most Recent Shareholder Update • GMER • Sep 25, 2024 8:30 AM
Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • BLOZF • Sep 24, 2024 8:50 AM
Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • INTV • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM